Novo Nordisk Education Foundation (NNEF) is a nonprofit organization founded in 1997 with the purpose of spreading awareness and imparting education on diagnosing, managing and control of Diabetes in India. NNEF has been founded by Novo Nordisk India Private Limited (NNIPL). NNIPL is the Indian subsidiary of Novo Nordisk AS (NNAS), a leading global healthcare company, founded in 1923 and headquartered in Denmark. NN purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. NN does so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure diseases. NN employs about 78,400 people in 80 countries and markets its products in around 170 countries.
NNEF work primarily involves creating capacity in healthcare resources, spreading awareness about diabetes and concomitant complications, and creating linkages with government to function through the public private partnership (PPP) model in order to create a sustainable community diabetes management programme in India. The PPP allows both the stakeholders to leverage NNEF’s global expertise in the management of diabetes and other chronic diseases, and to channel it efficiently through the administrative resources of various states. It thus creates a model which enables the best use of government resources for world-class diabetes management solutions and hence, is efficient, effective, and economical. The NNEF initiatives are aimed to improve lives of people with diabetes and other chronic diseases in India and reduce costs associated with them.
Mission: Enhancing healthcare by facilitating awareness and education.
As per our mission we collaborate with key stakeholders and like-minded partners on key initiatives to bring about awareness and education to tackle the burden of diabetes and other chronic diseases. As an offshoot of this we also have structured programmes reaching out to people and healthcare professionals.
Focus:
Increasing awareness by educating vulnerable population, doctors, educators, paramedics and public in general can help to control the epidemic of diabetes and other chronic diseases. The main challenge is to reduce the human and financial costs through early diagnosis and effective management and to prevent new cases.
Purpose and objectives:
The foundation hopes to improve healthcare, by facilitating:
• Awareness and patient empowerment programs
• Paitent education
• Detection drives and formation of registries
• Care standardization and up-gradation
.jpg)
Mr. Vikrant Shrotriya
Managing Trustee, Novo Nordisk Education Foundation
“With around 1 million children and youth in India living with T1D, it’s crucial to address their urgent needs. Through this public-private partnership with the state government, we can accelerate reach, improve healthcare infrastructure, and drive sustainable quality Type 1 diabetes care. The CoE provides holistic care through a host of services, including point-of-care HbA1C screening, certified diabetes educator counselling, specialists for regular health check-ups, progress monitoring, nutrition education, and efforts to strengthen the overall T1D care ecosystem. Additionally, we advocate for policy change at both the state and central levels.”
.jpg)
Mr. John Dawber
CVP & Managing Director, GBS
"Despite following & supporting Team Novo Nordisk for 12 years now, across 4 countries, I'm always humbled by the impact they have. Firstly, lives are changed & families are inspired, one at a time, by the stories of the TNN athletes. Secondly, our employees are brought close to our purpose, in a unique and lasting way. Finally, stakeholders, payors and policymakers can't fail to acknowledge the importance of prioritizing Diabetes. In our ever more competitive commercial space, Team Novo Nordisk stands out as a beacon of differentiation which our founders would be proud of."
Dr. Vijay Shekhar Reddy
Gandhi Medical College and Hospital, Secunderabad
"I am incredibly inspired by a robust model of care centered on access, equity, and community. The CoEs are significantly improving the quality of life for many children living with Type 1 diabetes in India. This model is designed to establish the much-needed standard-of-care for T1D, focusing on diagnosis, education, and counselling. Additionally, the e-registry platform helps physicians track patients, increase follow-up rates, and identify high-risk patients, ensuring comprehensive healthcare services at OPD."
Dr. Vani H N
Indira Gandhi Institute of Child Health, Bangalore
"In India, Type 1 diabetes is growing at 6.7% annually compared to 4.4% for Type 2 diabetes (T2D). The significant prevalence of this condition is a serious cause for alarm. NNEF'S efforts in enhancing public awareness and reducing stigma, creating a child-friendly clinics, providing comprehensive training, and offering vernacular content for education on treatment, monitoring, dosage, and titration are crucial in addressing the core needs of children and youth living with Type 1 diabetes."
.jpg)
Dr. Edward D’Mello
STEP-IN Faculty and Organiser
Ex – Sr. Consultant, South Goa District Hospital
"Working in a government hospital, we realized the load of Diabetic patients that needed not only medications but counselling and their queries to be addressed. What better way than to empower the nurses to help. The STEP-IN program, conducted with the help of DHS and Novo Nordisk Education Foundation, filled this gap. It was a satisfying experience to be a part of this program. In fact, education and training of HCPs must be ongoing process, to help deliver better patient care."
.jpg)
Dr. Vandana Dhume
Director
Directorate of Health Services, Goa
"Our Changing Diabetes Barometer program has demonstrated the power of community engagement and collaboration in addressing a critical health issue. We are proud of the positive impact we've made on the lives of people with diabetes."
.jpg)
Dr. Rupa Naik
IDirector, Directorate of Health Services
Government of Goa
"I am honored to share my thoughts on the resounding success of the Tour de Diabetes 2024, organized on the 4th of November in collaboration with Novo Nordisk and Team Novo Nordisk. This event, held in commemoration of World Diabetes Day, was a testament to our collective commitment to raising awareness about diabetes and promoting a healthier future for all."
.jpg)
Dr. Mohanrao Dessai
Non - Communicable Disease Cell,
Directorate of Health Services, GoaChief Medical Officer
"By providing comprehensive support and education, we have empowered individuals to take control of their diabetes and achieve better health outcomes. We are committed to expanding this program to reach even more people."
.jpg)
Dr. Kedar Raikar
Nodal Officer,
Non - Communicable Disease Cell,
Directorate of Health Services, Goa
"Through collaborative efforts and innovative strategies, we've made significant strides in improving the quality of life for individuals living with diabetes."
